210 related articles for article (PubMed ID: 26059279)
1. Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
Sanchez-Correa B; Campos C; Pera A; Bergua JM; Arcos MJ; Bañas H; Casado JG; Morgado S; Duran E; Solana R; Tarazona R
Cancer Immunol Immunother; 2016 Apr; 65(4):453-63. PubMed ID: 26059279
[TBL] [Abstract][Full Text] [Related]
2. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
[TBL] [Abstract][Full Text] [Related]
3. Immunosenescence of human natural killer cells.
Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
[TBL] [Abstract][Full Text] [Related]
4. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy with double-bright (CD56
Silla L; Valim V; Pezzi A; da Silva M; Wilke I; Nobrega J; Vargas A; Amorin B; Correa B; Zambonato B; Scherer F; Merzoni J; Sekine L; Huls H; Cooper LJ; Paz A; Lee DA
Br J Haematol; 2021 Dec; 195(5):710-721. PubMed ID: 34490616
[TBL] [Abstract][Full Text] [Related]
6. Age-related changes in natural killer cell receptors from childhood through old age.
Almeida-Oliveira A; Smith-Carvalho M; Porto LC; Cardoso-Oliveira J; Ribeiro Ados S; Falcão RR; Abdelhay E; Bouzas LF; Thuler LC; Ornellas MH; Diamond HR
Hum Immunol; 2011 Apr; 72(4):319-29. PubMed ID: 21262312
[TBL] [Abstract][Full Text] [Related]
7. Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant.
Velardi A; Ruggeri L; Mancusi A
Curr Opin Hematol; 2012 Jul; 19(4):319-23. PubMed ID: 22555394
[TBL] [Abstract][Full Text] [Related]
8. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
[TBL] [Abstract][Full Text] [Related]
9. Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
Tarazona R; Sanchez-Correa B; Casas-Avilés I; Campos C; Pera A; Morgado S; López-Sejas N; Hassouneh F; Bergua JM; Arcos MJ; Bañas H; Casado JG; Durán E; Labella F; Solana R
Cancer Immunol Immunother; 2017 Feb; 66(2):233-245. PubMed ID: 27530271
[TBL] [Abstract][Full Text] [Related]
10. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
12. NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
Romero AI; Thorén FB; Brune M; Hellstrand K
Br J Haematol; 2006 Jan; 132(1):91-8. PubMed ID: 16371024
[TBL] [Abstract][Full Text] [Related]
13. Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands.
Sanchez-Correa B; Morgado S; Gayoso I; Bergua JM; Casado JG; Arcos MJ; Bengochea ML; Duran E; Solana R; Tarazona R
Cancer Immunol Immunother; 2011 Aug; 60(8):1195-205. PubMed ID: 21644031
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities.
Le Roy A; Prébet T; Castellano R; Goubard A; Riccardi F; Fauriat C; Granjeaud S; Benyamine A; Castanier C; Orlanducci F; Ben Amara A; Pont F; Fournié JJ; Collette Y; Mege JL; Vey N; Olive D
Front Immunol; 2018; 9():977. PubMed ID: 29780393
[TBL] [Abstract][Full Text] [Related]
15. CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.
Wang Y; Bo J; Dai HR; Lu XC; Lv HY; Yang B; Wang T; Han WD
Exp Hematol; 2013 Mar; 41(3):241-52.e3. PubMed ID: 23123634
[TBL] [Abstract][Full Text] [Related]
16. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell immune escape in acute myeloid leukemia.
Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
[TBL] [Abstract][Full Text] [Related]
18. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
19. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.
Rohner A; Langenkamp U; Siegler U; Kalberer CP; Wodnar-Filipowicz A
Leuk Res; 2007 Oct; 31(10):1393-402. PubMed ID: 17391757
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
